ArticleBMJ open sport & exercise medicine2025
Effects of photobiomodulation therapy combined with static magnetic field on training adaptations and detraining responses: a randomised placebo-controlled trial.
Article in BMJ open sport & exercise medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03858179 (Effects of Photobiomodulation Therapy in Strength Training and Detraining in Humans), which is not on this map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Effects of Photobiomodulation Therapy in Strength Training and Detraining in Humans
Who cites it
1 citing paper in PubMed.
- Preliminary pre-post changes in neuromuscular performance after application of a wearable photobiomodulation device in young tennis athletes.European journal of translational myology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Although photobiomodulation therapy combined with static magnetic field (PBMT-sMF) has demonstrated benefits for enhancing performance and recovery when applied before or after exercise sessions, its effects on adaptations during periods without training after strength training protocols remain unexplored. Therefore, we aimed to evaluate the effects of PBMT-sMF on the maintenance of muscle strength and structural properties of the quadriceps during a 4-week detraining period following a 12-week resistance strength training programme. Methods: In this triple-blind, randomised, placebo-controlled trial, 48 healthy men were randomised to one of four groups: PBMT-sMF during both training and detraining, PBMT-sMF during training and placebo during detraining, placebo during training and PBMT-sMF during detraining or placebo throughout. All participants completed 12 weeks of unilateral resistance training (leg press and leg extension, twice weekly), followed by 4 weeks of detraining. PBMT-sMF or placebo was applied bilaterally to the anterior thigh prior to each session of exercise and two times per week during detraining. Outcomes included maximal voluntary contraction (MVC, primary outcome), as well as one-repetition maximum (1RM), muscle volume and anatomical cross-sectional area, measured at baseline and weeks 4, 8, 12 and 16. Results: PBMT-sMF significantly preserved muscle strength (MVC and 1RM) and structural features (volume and anatomical cross-sectional area) during detraining compared with placebo (p<0.05). The group that received PBMT-sMF during both the training and detraining phases demonstrated the greatest preservation across all outcomes. Conclusion: PBMT-sMF significantly attenuated strength loss and structural muscle changes during the detraining period after a resistance training programme. Trial registration number: NCT03858179.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.